UK: The Home Office has stated in written evidence to a parliamentary inquiry into drug policy that the government is keen to reduce barriers to access to controlled drugs for legitimate medical, research and industrial purposes. As an example, it refers to the introduction of cannabis-based products for medicinal use. However, the department does not seem keen on […] ...
